• Je něco špatně v tomto záznamu ?

The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus

D. Benak, S. Benakova, L. Plecita-Hlavata, M. Hlavackova

. 2023 ; 14 (-) : 1223583. [pub] 20230707

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016908

The rapidly developing research field of epitranscriptomics has recently emerged into the spotlight of researchers due to its vast regulatory effects on gene expression and thereby cellular physiology and pathophysiology. N6-methyladenosine (m6A) and N6,2'-O-dimethyladenosine (m6Am) are among the most prevalent and well-characterized modified nucleosides in eukaryotic RNA. Both of these modifications are dynamically regulated by a complex set of epitranscriptomic regulators called writers, readers, and erasers. Altered levels of m6A and also several regulatory proteins were already associated with diabetic tissues. This review summarizes the current knowledge and gaps about m6A and m6Am modifications and their respective regulators in the pathophysiology of diabetes mellitus. It focuses mainly on the more prevalent type 2 diabetes mellitus (T2DM) and its treatment by metformin, the first-line antidiabetic agent. A better understanding of epitranscriptomic modifications in this highly prevalent disease deserves further investigation and might reveal clinically relevant discoveries in the future.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016908
003      
CZ-PrNML
005      
20231026105456.0
007      
ta
008      
231013s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fendo.2023.1223583 $2 doi
035    __
$a (PubMed)37484960
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Benak, Daniel $u Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia $u Department of Physiology, Faculty of Science, Charles University, Prague, Czechia
245    14
$a The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus / $c D. Benak, S. Benakova, L. Plecita-Hlavata, M. Hlavackova
520    9_
$a The rapidly developing research field of epitranscriptomics has recently emerged into the spotlight of researchers due to its vast regulatory effects on gene expression and thereby cellular physiology and pathophysiology. N6-methyladenosine (m6A) and N6,2'-O-dimethyladenosine (m6Am) are among the most prevalent and well-characterized modified nucleosides in eukaryotic RNA. Both of these modifications are dynamically regulated by a complex set of epitranscriptomic regulators called writers, readers, and erasers. Altered levels of m6A and also several regulatory proteins were already associated with diabetic tissues. This review summarizes the current knowledge and gaps about m6A and m6Am modifications and their respective regulators in the pathophysiology of diabetes mellitus. It focuses mainly on the more prevalent type 2 diabetes mellitus (T2DM) and its treatment by metformin, the first-line antidiabetic agent. A better understanding of epitranscriptomic modifications in this highly prevalent disease deserves further investigation and might reveal clinically relevant discoveries in the future.
650    _2
$a lidé $7 D006801
650    _2
$a messenger RNA $x metabolismus $7 D012333
650    12
$a diabetes mellitus 2. typu $x genetika $7 D003924
650    _2
$a adenosin $x metabolismus $7 D000241
650    _2
$a RNA $x genetika $x metabolismus $7 D012313
650    _2
$a posttranskripční úpravy RNA $7 D012323
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Benakova, Stepanka $u Laboratory of Pancreatic Islet Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia $u First Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Plecita-Hlavata, Lydie $u Laboratory of Pancreatic Islet Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Hlavackova, Marketa $u Laboratory of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
773    0_
$w MED00174543 $t Frontiers in endocrinology $x 1664-2392 $g Roč. 14, č. - (2023), s. 1223583
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37484960 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105451 $b ABA008
999    __
$a ok $b bmc $g 2000436 $s 1203270
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1223583 $e 20230707 $i 1664-2392 $m Frontiers in endocrinology $n Front. endocrinol. $x MED00174543
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace